For: | Zapater P, González-Navajas JM, Such J, Francés R. Immunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosis. World J Gastroenterol 2015; 21(41): 11493-11501 [PMID: 26556982 DOI: 10.3748/wjg.v21.i41.11493] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i41/11493.htm |
Number | Citing Articles |
1 |
Yongguo Cao, Xufeng Xie, Wenlong Zhang, Dianjun Wu, Changchun Tu. Low-dose Norfloxacin-treated leptospires induce less IL-1β release in J774A.1 cells following discrepant leptospiral gene expression. Microbial Pathogenesis 2018; 119: 125 doi: 10.1016/j.micpath.2018.03.032
|
2 |
Markus Kimmann, Tammo Lambert Tergast, Marie Schultalbers, Hans Laser, Svetlana Gerbel, Michael Peter Manns, Markus Cornberg, Benjamin Maasoumy, Tatsuo Kanda. Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis. PLOS ONE 2019; 14(8): e0220666 doi: 10.1371/journal.pone.0220666
|
3 |
Yong-Tao Li, Jian-Rong Huang, Mei-Lian Peng. Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/3743962
|
4 |
Morena Zusso, Valentina Lunardi, Davide Franceschini, Andrea Pagetta, Rita Lo, Stefano Stifani, Anna Chiara Frigo, Pietro Giusti, Stefano Moro. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway. Journal of Neuroinflammation 2019; 16(1) doi: 10.1186/s12974-019-1538-9
|
5 |
Yujing Fan, Yunpeng Li, Yanjie Chu, Jing Liu, Lin Cui, Dekai Zhang. Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.608498
|
6 |
M. A. Oke, F. J. Afolabi, O. O. Oyeleke, T. A. Kilani, A. R. Adeosun, A. A. Olanbiwoninu, E. A. Adebayo. Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.952027
|
7 |
Anasuya Patel, Ganesh V. Sangle, Jinal Trivedi, Sushant A. Shengule, Deepak Thorve, Mohan Patil, Nitin J. Deshmukh, Bhushan Choudhari, Avinash Karade, Sangita Gupta, Sachin Bhagwat, Mahesh Patel. Levonadifloxacin, a Novel Benzoquinolizine Fluoroquinolone, Modulates Lipopolysaccharide-Induced Inflammatory Responses in Human Whole-Blood Assay and Murine Acute Lung Injury Model. Antimicrobial Agents and Chemotherapy 2020; 64(5) doi: 10.1128/AAC.00084-20
|
8 |
Arshi Khanam, Shyam Kottilil. Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.752875
|
9 |
Lianqiang Che, Qin Xu, Cheng Wu, Yuheng Luo, Xiaobo Huang, Bo Zhang, Eric Auclair, Tadele Kiros, Zhengfeng Fang, Yan Lin, Shengyu Xu, Bin Feng, Jian Li, De Wu. Effects of dietary live yeast supplementation on growth performance, diarrhoea severity, intestinal permeability and immunological parameters of weaned piglets challenged with enterotoxigenic Escherichia coli K88. British Journal of Nutrition 2017; 118(11): 949 doi: 10.1017/S0007114517003051
|
10 |
Melisa Dirchwolf, Sebastián Marciano, José Martínez, Andrés Eduardo Ruf. Unresolved issues in the prophylaxis of bacterial infections in patients with cirrhosis. World Journal of Hepatology 2018; 10(12): 892-897 doi: 10.4254/wjh.v10.i12.892
|
11 |
Anne Geng, Emilio Flint, Christine Bernsmeier. Plasticity of monocytes and macrophages in cirrhosis of the liver. Frontiers in Network Physiology 2022; 2 doi: 10.3389/fnetp.2022.937739
|
12 |
Mohammed Sharif Swallah, Precious Bondzie-Quaye, Han Wang, Chang-Sheng Shao, Pei Hua, Mona Alrasheed Bashir, Joseph Benjamin Holman, Frederick Leo Sossah, Qing Huang. Potentialities of Ganoderma lucidum extracts as functional ingredients in food formulation. Food Research International 2023; 172: 113161 doi: 10.1016/j.foodres.2023.113161
|
13 |
Nakarin Suwannarach, Jaturong Kumla, Kanaporn Sujarit, Thanawat Pattananandecha, Chalermpong Saenjum, Saisamorn Lumyong. Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses. Molecules 2020; 25(8): 1800 doi: 10.3390/molecules25081800
|